What is Mohs micrographic surgery?
Mohs micrographic surgery (often just called Mohs surgery) is a precise way of removing skin cancer one thin layer at a time. After each layer is removed, the surgeon examines all of its edges under the microscope while the patient waits. If cancer is still present at any edge, the surgeon maps exactly where it is and removes another thin layer only from that spot. The process is repeated until the edges are clear.
The technique is named after Dr Frederic Mohs, an American surgeon who developed it in the 1930s. Modern Mohs surgery uses frozen tissue sections that can be prepared in about an hour, so the whole treatment usually takes place in one day under local anaesthetic.
The main advantages are a very high cure rate and the ability to save as much healthy skin as possible. This is especially valuable on the face, eyelids, nose, lips and ears, where every millimetre of skin matters for appearance and function.
How it differs from standard excision
| Feature | Standard excision | Mohs surgery |
|---|---|---|
| Margin | A fixed margin of normal-looking skin is cut around the tumour | Only as much skin as needed is removed |
| Margin check | A sample of the edges is checked in the laboratory days later | Close to 100% of the edge is checked on the same day |
| Anaesthetic | Local or general | Almost always local |
| Timing of repair | Often at the same time, before results are known | After the edges are confirmed clear |
| Time in clinic | About an hour | Several hours |
| Best suited for | Low-risk tumours in less critical areas | High-risk tumours or sensitive sites |
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of treatment | Skin surgery with same-day microscopic margin control |
| Main uses | Basal cell and squamous cell carcinoma, especially on the face; selected rarer skin cancers |
| Anaesthetic | Local anaesthetic injection |
| Time needed | Usually 2-6 hours, sometimes a full day |
| Number of stages | Often 1-2; occasionally more |
| Repair | Stitches, a skin flap, a skin graft or natural healing |
| Recovery | Most people return to normal activities within a few days to two weeks |
| Main risks | Bleeding, infection, scarring, numbness |
2. How it works
Skin cancers often have roots that extend beyond what can be seen on the surface. These roots can be irregular and unpredictable, especially in recurrent tumours or aggressive growth patterns. Mohs surgery follows these roots precisely.
| Step | Purpose |
|---|---|
| Removing a saucer-shaped layer | Takes the visible tumour with a narrow rim of skin |
| Mapping the tissue | The layer is marked with coloured dyes and drawn on a map of the wound |
| Horizontal sectioning | The tissue is flattened and cut so that the entire deep and side edges can be seen on one slide |
| Same-day microscopy | The Mohs surgeon reads the slides while you wait |
| Targeted re-excision | Only areas with remaining cancer are cut again |
In standard pathology, the specimen is usually cut like slices of bread, and only a small proportion of the edge is examined. Mohs sectioning looks at almost the entire edge, which is why it misses fewer cancer roots.
3. Who it is for
Expert groups have published appropriate use criteria describing when Mohs surgery is most likely to help. They considered 270 clinical scenarios and judged Mohs to be appropriate in about three-quarters of them, mostly for tumours on the head and neck, recurrent tumours and aggressive subtypes (Ad Hoc Task Force et al., 2012).
Conditions treated
| Condition | When Mohs is used |
|---|---|
| Basal cell carcinoma | Face and other high-risk sites, recurrent tumours, aggressive growth patterns |
| Squamous cell carcinoma | High-risk tumours, especially on the face, ears and lips |
| Bowen disease | Larger lesions on the face or fingers, or recurrent lesions |
| Lentigo maligna melanoma | Melanoma in situ on the face, often with special stains |
| Dermatofibrosarcoma protuberans | Tumour with long, irregular extensions |
| Microcystic adnexal carcinoma | Deeply infiltrating sweat gland cancer |
| Sebaceous carcinoma | Especially on the eyelid |
| Extramammary Paget disease | Ill-defined edges in the genital or perianal skin |
| Atypical fibroxanthoma | Sun-damaged skin of the head and neck |
Features that favour Mohs
| Feature | Examples |
|---|---|
| Location | Nose, eyelids, lips, ears, around the eyes, fingers, genitals |
| Size | Larger tumours, especially on the face |
| Growth pattern | Infiltrative, morphoeic or micronodular basal cell carcinoma |
| History | Tumours that have come back after previous treatment |
| Edges | Poorly defined borders |
| Patient factors | Weakened immune system, previous radiotherapy to the area |
When Mohs is usually not needed
Small, low-risk tumours on the trunk or limbs are usually treated well with standard excision, curettage or other simpler methods. In these situations Mohs adds time and cost without clear benefit.
4. Before the procedure
| Step | Details |
|---|---|
| Biopsy | The diagnosis is usually confirmed by a biopsy beforehand |
| Consultation | The surgeon checks the site and explains the likely repair |
| Medicines | Blood thinners are usually continued; tell your team about all medicines |
| Photographs | The site may be photographed so it can be found again |
| Practical planning | Arrange transport home, especially for sites near the eyes |
| On the day | Eat a normal breakfast, bring a book, snacks and any regular medicines |
5. What to expect: step by step
| Step | What happens |
|---|---|
| 1. Preparation | The area is cleaned and marked |
| 2. Local anaesthetic | Injections numb the skin; this stings briefly |
| 3. First layer | The visible tumour and a thin rim of tissue are removed |
| 4. Temporary dressing | The wound is covered while you wait |
| 5. Laboratory processing | The tissue is frozen, cut, stained and placed on slides; this takes around 30-60 minutes |
| 6. Microscope check | The surgeon looks for cancer at the edges |
| 7. More layers if needed | If cancer remains, more tissue is removed from that exact spot and the cycle repeats |
| 8. Clear margins | When no cancer is seen, the removal stage is finished |
| 9. Repair | The wound is closed with stitches, a flap or a graft, or left to heal naturally |
| 10. Dressing and advice | You receive a pressure dressing and wound care instructions |
How long it takes
Most of the day is spent waiting while slides are prepared. Many tumours are cleared after one or two stages. Larger or recurrent tumours can need several stages and a longer day. Occasionally, a complex repair is done on a separate day by a plastic or oculoplastic surgeon.
Types of repair
| Repair | Description |
|---|---|
| Natural healing | Small wounds in concave areas may heal well on their own |
| Direct closure | Edges are stitched together in a line |
| Local flap | Nearby skin is moved to cover the wound |
| Skin graft | Skin is taken from another site, such as in front of or behind the ear |
6. Side effects and risks
| Side effect or risk | How common | Notes |
|---|---|---|
| Pain | Common, usually mild | Simple painkillers are usually enough |
| Bruising and swelling | Common | More marked around the eyes; may spread down the face |
| Bleeding | Uncommon | Usually controlled with firm pressure for 20 minutes |
| Infection | Uncommon | Redness, heat or discharge; treated with antibiotics |
| Scar | Expected | Usually fades over 6-12 months |
| Numbness | Common | Small skin nerves are cut; feeling often returns over months |
| Flap or graft problems | Uncommon | Part of the flap or graft may not take |
| Nerve weakness | Rare | If a motor nerve near the surface is affected |
| Recurrence | Low | Further treatment may be needed |
7. Results and outlook
Mohs surgery has some of the lowest recurrence rates of any skin cancer treatment.
| Evidence | Main finding |
|---|---|
| Meta-analysis of 17 studies | Recurrence about 3.1% after micrographic surgery versus 5.3% after conventional excision; the benefit was clearest for basal cell carcinoma and primary tumours (Lacerda et al., 2024) |
| Review of basal cell carcinoma data | Mohs is viewed as the gold standard for high-risk basal cell carcinoma, though randomised evidence is limited (Brown et al., 2022) |
| Melanoma review | For melanoma in situ and selected invasive melanomas, local recurrence and survival were similar to or better than wide local excision (Shah et al., 2024) |
The review of basal cell carcinoma noted some evidence that Mohs leaves a smaller wound, although direct proof of a better cosmetic result is lacking, and cost comparisons vary between healthcare systems (Brown et al., 2022).
8. Recovery and aftercare
Recovery timeline
| Period | What to expect |
|---|---|
| First 24-48 hours | Keep the pressure dressing on and dry; rest and avoid bending |
| Days 2-7 | Gentle cleaning and new dressings as instructed; swelling peaks then eases |
| Days 7-14 | Stitches removed if they are not dissolvable |
| Weeks 2-6 | Wound heals; avoid heavy exercise early on if advised |
| Months 3-12 | Scar softens and fades |
Wound care tips
- Keep the head raised on pillows for the first nights after facial surgery
- Avoid alcohol and strenuous exercise for a few days to reduce bleeding
- Use petroleum jelly on the wound if advised, to keep it moist
- Do not smoke, as it slows healing and can cause flaps or grafts to fail
- Contact your team for bleeding that does not stop with pressure, or signs of infection
Long-term follow-up
People who have had one skin cancer have a higher chance of developing another. Regular skin checks, daily sun protection and prompt reporting of new or changing spots are important.
| Check | Typical timing |
|---|---|
| Skin examination | Every 6-12 months, depending on risk |
| Self-checks | Monthly |
| Sun protection | Daily, all year round |
Living with the scar
Facial scars can feel very noticeable in the first weeks, when they are red and raised. Most settle and become paler and flatter over the following year. Gentle massage once the wound has healed, sun protection over the scar, and patience usually help. If a scar remains thick or pulls on nearby features, treatments such as steroid injections, laser or a small revision procedure can be discussed.
9. Alternatives
| Alternative | Best suited for |
|---|---|
| Standard surgical excision | Most low-risk basal and squamous cell carcinomas |
| Curettage and cautery | Small, superficial, low-risk tumours |
| Cryotherapy | Small superficial lesions |
| Topical treatments (imiquimod, 5-fluorouracil) | Superficial basal cell carcinoma and Bowen disease |
| Photodynamic therapy | Superficial basal cell carcinoma and Bowen disease |
| Radiotherapy | People unable to have surgery, or difficult sites |
| Hedgehog pathway inhibitors or immunotherapy | Advanced or inoperable tumours |
10. Frequently asked questions
| Question | Answer |
|---|---|
| Will I be awake? | Yes; local anaesthetic numbs the area and you can talk and rest between stages |
| How big will the wound be? | Often bigger than the visible spot, because roots are removed too |
| Can I drive home? | Not if the surgery is near your eyes or a large dressing blocks your vision |
| Is it painful? | The injections sting; afterwards most people need only simple painkillers |
| Will I need a second operation? | Usually not, unless a complex repair is planned separately |
| Can the cancer come back? | It is uncommon, but regular skin checks are still important |
| Is Mohs used for melanoma? | For some melanomas in situ and early melanomas, particularly on the face |
11. Questions to ask your care team
- Why is Mohs surgery recommended for my skin cancer?
- How many stages do you expect?
- What kind of repair will I need, and what will the scar look like?
- Should I stop any medicines before the day?
- Will I be able to drive or work the next day?
- How should I care for the wound?
- How often should I have skin checks?
Resources
- Ad Hoc Task Force et al. (2012) ‘AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery’, Journal of the American Academy of Dermatology, 67(4), pp. 531-550.
- Brown, A.C. et al. (2022) ‘A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma’, Clinical and Experimental Dermatology, 47(10), pp. 1794-1804.
- Lacerda, P.N. et al. (2024) ‘Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: a systematic review and meta-analysis’, Journal of the European Academy of Dermatology and Venereology, 38(6), pp. 1058-1069.
- Shah, P. et al. (2024) ‘Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: a clinical review of treatment efficacy and ongoing controversies’, Journal of the American Academy of Dermatology, 91(3), pp. 499-507.
- National Cancer Institute (2026) Skin Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/skin/hp/skin-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.